Little Green Pharma Ltd. announced its entry into an exclusive agreement with PharmaServe Hellas SMSACI for the distribution of LGP-branded oil medicines and cannabis flower in Greece. Under the Agreement, PharmaServe agrees to exclusively distribute LGP cannabis medicines and not promote any other cannabis medicine in Greece for at least 2 years, with further exclusivity periods to be extended by agreement. In return, LGP will exclusively distribute its cannabis medicines through PharmaServe in Greece for this 2-year period.

The Company will supply the medicines from its Australian and Danish facilities (subject to deposit prepayment terms) and will share product revenues on a 50:50 basis, subject to LGP receiving certain minimum prices per unit. Material terms of the Agreement: The Agreement is conditional upon PharmaServe obtaining a Marketing Authorisation to distribute the LGP cannabis medicines in Greece. LGP's exclusivity obligations are conditional upon PharmaServe achieving minimum revenues of 600,000 per year and there are no minimum quantity commitments under the Agreement.

After a period of 2 years, PharmaServe may also require LGP to supply co-branded cannabis medicines in addition to the LGP branded medicines for prices to be agreed.